ArticleBlood advances2022

Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis.

Danny Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.